{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:50:21Z","timestamp":1778482221009,"version":"3.51.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography (Ga-68 PSMA PET\/CT) is an imaging modality that promises improved sensitivity and specificity of detection of prostate cancer lesions based on their increased uptake of PSMA-based radiotracers. It remains an emerging modality that has not yet been endorsed in the guidelines for the management of prostate cancer pending more established evidence to prove its efficacy. The objective of the study is to assess the value of Ga-68 PSMA PET\/CT in the detection and localization of patients diagnosed with intermediate or high risk prostate cancer.<\/jats:p>\n            <jats:p>Twenty three patients with intermediate or high risk prostate cancer had undergone Ga-68 PSMA PET\/CT imaging prior to robotic assisted radical prostatectomy. Surgical specimens were then submitted for histological examinations. Lesions visualized on PET\/CT and histology were independently mapped unto a 36-segment (Prostate Imaging Reporting and Data System version 2 [PI-RADS v.2]) map of the prostate. Concordance of visualization on PET\/CT as compared to the histology as gold standard reference was then assessed. Lesions visualized on PET\/CT and histology were independently mapped unto a 36-segment (PI-RADS v.2) map of the prostate. Concordance of visualization on PET\/CT as compared to the histology as gold standard reference was then assessed.<\/jats:p>\n            <jats:p>Sensitivity for all lesions identified on Ga-68 PSMA PET\/CT was 42.37%; specificity was 88.61%. Both parameters were higher when considering only index lesions for which sensitivity was 68.42% and specificity was 98.23%. Sensitivity for the index lesions in intermediate risk group was 53.2% and was higher in the high risk group reaching 83.33%.<\/jats:p>\n            <jats:p>Ga-68 PSMA PET\/CT provides accurate localization of tumor lesions in patients with intermediate and high risk prostate cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017491","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:38:47Z","timestamp":1572896327000},"page":"e17491","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography in intermediate and high risk prostate cancer"],"prefix":"10.1097","volume":"98","author":[{"given":"Albert","family":"El Hajj","sequence":"first","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel","family":"Yacoub","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Mansour","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Khauli","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Bulbul","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Nassif","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad B","family":"Haidar","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bju.13739","article-title":"Clinical impact of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission tomography\/computed tomography (PET\/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach","volume":"120","author":"Albisinni","year":"2017","journal-title":"BJU Int"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrurol.2016.26","article-title":"Current use of PSMA-PET in prostate cancer management","volume":"13","author":"Maurer","year":"2016","journal-title":"Nat Rev Urol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.juro.2018.01.002","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part II: recommended approaches and details of specific care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41391-018-0048-7","article-title":"68 Ga-PSMA PET\/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology","volume":"21","author":"Berger","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","article-title":"Improved specificity with 68 Ga PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology","volume":"46","author":"Donato","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2967\/jnumed.116.172627","article-title":"68Ga-PSMA PET\/CT detects the location and extent of primary prostate cancer","volume":"57","author":"Fendler","year":"2016","journal-title":"J Nucl Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jmri.23938","article-title":"Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology","volume":"37","author":"Isebaert","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u2013reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","article-title":"Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68 Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI","volume":"44","author":"Freitag","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MNM.0000000000000290","article-title":"Evaluation of PSMA PET\/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging","volume":"36","author":"Kabasakal","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00259-016-3578-z","article-title":"Early dynamic imaging in 68Ga- PSMA-11 PET\/CT allows discrimination of urinary bladder activity and prostate cancer lesions","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/ijnm.IJNM_8_18","article-title":"Role of early dynamic positron emission tomography\/computed tomography with 68Ga-prostate-specific membrane antigen-HBED-CC in patients with adenocarcinoma prostate: initial results","volume":"33","author":"Perveen","year":"2018","journal-title":"Indian J Nucl Med"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1038\/s41598-018-22594-1","article-title":"PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis","volume":"8","author":"Bravaccini","year":"2018","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:35:25Z","timestamp":1694824525000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":16,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017491","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}